Teva Pharmaceutical Industries Ltd Insider Trading

TEVA

Last 12 months

Insiders sold $113M and bought nothing on the open market.

61% of the selling was scheduled in advance under 10b5-1 plans. Director Roberto Mignone sold $14.4M on Sep 18, 75% of their stake, outside a plan. The last open-market buy by an executive or director was in Sep 2025.

Net open-market

−$113M

0 buys · 46 sales

Under a 10b5-1 plan

61%

of the value sold

Insiders who bought / sold

0 / 14

executives and directors

Last open-market buy

Sep 2025

Sep 5, 2025

Get an email when TEVA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 18	Brian Savage Interim Chief Legal Officer	SoldNo plan 3 parts	7,342	$38.85 average	285K	46%	Form 4
Sep 18	Roberto Mignone Director	SoldNo plan	367,600	$39.06	$14.4M	75%	Form 4
Aug 21	Amir Weiss Chief Accounting Officer	SoldNo plan 2 parts	9,445	$37.62 average	355K	42%	Form 4
Aug 21	Ronit Satchi-Fainaro Director	SoldNo plan	415	$37.25	15K	0.4%	Form 4
Aug 17	Evan Lippman EVP, Business Development	Sold10b5-1 plan	18,600	$36.57	680K	42%	Form 4
Aug 5	Tal Zvi Zaks Director	SoldNo plan	17	$34.87	$593	<0.1%	Form 4
Aug 3	Placid Jover "See ""Remarks"""	Sold10b5-1 plan	12,827	$34.88	447K	65%	Form 4
Aug 3	Eric A Hughes "See ""Remarks"""	Sold10b5-1 plan	25,578	$34.88	892K	16%	Form 4
Jun 18	Matthew Shields EVP, Global Operations	SoldNo plan	9,989	$32.19	322K	100%	Form 4
Jun 11	Eliyahu Sharon Kalif EVP, Chief Financial Officer	Sold10b5-1 plan	106,563	$34.10	$3.63M	62%	Form 4
Jun 5	Richard D Francis President and CEO	Sold10b5-1 plan	6,153	$34.35	211K	0.5%	Form 4
Jun 3	Matthew Shields EVP, Global Operations	Sold10b5-1 plan	16,195	$32.87	532K	62%	Form 4
May 14	Evan Lippman EVP, Business Development	Sold10b5-1 plan 2 parts	41,658	$35.58 average	$1.48M	49%	Form 4
May 14	Eliyahu Sharon Kalif EVP, Chief Financial Officer	Sold10b5-1 plan	153,251	$35.61	$5.46M	47%	Form 4
May 6	Amir Weiss Chief Accounting Officer	SoldNo plan	10,679	$36.00	384K	35%	Form 4
May 5	Richard Daniell EVP, Europe Commercial	SoldNo plan	30,000	$35.40	$1.06M	35%	Form 4
May 1	Mark Sabag "See ""Remarks"""	SoldNo plan	144,180	$34.99	$5.04M	64%	Form 4
Apr 30	Christine Fox EVP, U.S. Commercial	SoldNo plan	21,258	$35.31	751K	25%	Form 4
Mar 17	Mark Sabag "See ""Remarks"""	SoldNo plan	62,102	$30.14	$1.87M	22%	Form 4
Mar 5	Richard D Francis President and CEO	Sold10b5-1 plan	20,025	$31.67	634K	1.7%	Form 4
Mar 5	Christine Fox EVP, U.S. Commercial	Sold10b5-1 plan	7,924	$31.67	251K	8.5%	Form 4
Mar 5	Eric A Hughes "See ""Remarks"""	Sold10b5-1 plan	9,533	$31.67	302K	8.1%	Form 4
Mar 5	Richard Daniell EVP, Europe Commercial	Sold10b5-1 plan	17,295	$31.67	548K	17%	Form 4
Mar 5	Placid Jover "See ""Remarks"""	Sold10b5-1 plan	14,150	$31.67	448K	68%	Form 4
Mar 5	Brian Savage Interim Chief Legal Officer	SoldNo plan	1,127	$31.67	36K	9.4%	Form 4
Mar 5	Matthew Shields EVP, Global Operations	Sold10b5-1 plan	17,295	$31.67	548K	63%	Form 4
Mar 4	Richard D Francis President and CEO	Sold10b5-1 plan	23,393	$32.46	759K	2.0%	Form 4
Mar 4	Richard Daniell EVP, Europe Commercial	Sold10b5-1 plan 3 parts	91,345	$32.66 average	$2.98M	52%	Form 4
Mar 4	Eric A Hughes "See ""Remarks"""	Sold10b5-1 plan	11,277	$32.46	366K	10%	Form 4
Mar 4	Christine Fox EVP, U.S. Commercial	Sold10b5-1 plan	9,098	$32.46	295K	11%	Form 4
Mar 4	Brian Savage Interim Chief Legal Officer	SoldNo plan 2 parts	2,675	$32.46 average	87K	24%	Form 4
Mar 3	Richard Daniell EVP, Europe Commercial	Sold10b5-1 plan 2 parts	128,985	$32.36 average	$4.17M	51%	Form 4
Mar 3	Brian Savage Interim Chief Legal Officer	SoldNo plan	1,274	$32.36	41K	30%	Form 4
Mar 3	Richard D Francis President and CEO	Sold10b5-1 plan 2 parts	442,935	$32.36 average	$14.3M	28%	Form 4
Mar 3	Eric A Hughes "See ""Remarks"""	Sold10b5-1 plan 2 parts	80,762	$32.36 average	$2.61M	49%	Form 4
Feb 26	Eliyahu Sharon Kalif EVP, Chief Financial Officer	Sold10b5-1 plan	345,810	$33.64	$11.6M	86%	Form 4
Feb 15	Richard D Francis President and CEO	Sold10b5-1 plan 2 parts	447,778	$34.22 average	$15.3M	43%	Form 4
Dec 16, 2025	Amir Weiss Chief Accounting Officer	SoldNo plan	12,300	$30.20	371K	69%	Form 4
Dec 16, 2025	Roberto Mignone Director	SoldNo plan	77,400	$30.24	$2.34M	14%	Form 4
Dec 9, 2025	Richard Daniell Exec. VP, European Commercial	SoldNo plan	115,468	$28.68	$3.31M	70%	Form 4

Sep 18No plan
Brian Savage
Interim Chief Legal Officer · sold 7,342 at avg $38.85
285K
46% of stake
Sep 18No plan
Roberto Mignone
Director · sold 367,600 at $39.06
$14.4M
75% of stake
Aug 21No plan
Amir Weiss
Chief Accounting Officer · sold 9,445 at avg $37.62
355K
42% of stake
Aug 21No plan
Ronit Satchi-Fainaro
Director · sold 415 at $37.25
15K
0.4% of stake
Aug 1710b5-1 plan
Evan Lippman
EVP, Business Development · sold 18,600 at $36.57
680K
42% of stake
Aug 5No plan
Tal Zvi Zaks
Director · sold 17 at $34.87
$593
<0.1% of stake
Aug 310b5-1 plan
Placid Jover
"See ""Remarks""" · sold 12,827 at $34.88
447K
65% of stake
Aug 310b5-1 plan
Eric A Hughes
"See ""Remarks""" · sold 25,578 at $34.88
892K
16% of stake
Jun 18No plan
Matthew Shields
EVP, Global Operations · sold 9,989 at $32.19
322K
100% of stake
Jun 1110b5-1 plan
Eliyahu Sharon Kalif
EVP, Chief Financial Officer · sold 106,563 at $34.10
$3.63M
62% of stake
Jun 510b5-1 plan
Richard D Francis
President and CEO · sold 6,153 at $34.35
211K
0.5% of stake
Jun 310b5-1 plan
Matthew Shields
EVP, Global Operations · sold 16,195 at $32.87
532K
62% of stake
May 1410b5-1 plan
Evan Lippman
EVP, Business Development · sold 41,658 at avg $35.58
$1.48M
49% of stake
May 1410b5-1 plan
Eliyahu Sharon Kalif
EVP, Chief Financial Officer · sold 153,251 at $35.61
$5.46M
47% of stake
May 6No plan
Amir Weiss
Chief Accounting Officer · sold 10,679 at $36.00
384K
35% of stake
May 5No plan
Richard Daniell
EVP, Europe Commercial · sold 30,000 at $35.40
$1.06M
35% of stake
May 1No plan
Mark Sabag
"See ""Remarks""" · sold 144,180 at $34.99
$5.04M
64% of stake
Apr 30No plan
Christine Fox
EVP, U.S. Commercial · sold 21,258 at $35.31
751K
25% of stake
Mar 17No plan
Mark Sabag
"See ""Remarks""" · sold 62,102 at $30.14
$1.87M
22% of stake
Mar 510b5-1 plan
Richard D Francis
President and CEO · sold 20,025 at $31.67
634K
1.7% of stake
Mar 510b5-1 plan
Christine Fox
EVP, U.S. Commercial · sold 7,924 at $31.67
251K
8.5% of stake
Mar 510b5-1 plan
Eric A Hughes
"See ""Remarks""" · sold 9,533 at $31.67
302K
8.1% of stake
Mar 510b5-1 plan
Richard Daniell
EVP, Europe Commercial · sold 17,295 at $31.67
548K
17% of stake
Mar 510b5-1 plan
Placid Jover
"See ""Remarks""" · sold 14,150 at $31.67
448K
68% of stake
Mar 5No plan
Brian Savage
Interim Chief Legal Officer · sold 1,127 at $31.67
36K
9.4% of stake
Mar 510b5-1 plan
Matthew Shields
EVP, Global Operations · sold 17,295 at $31.67
548K
63% of stake
Mar 410b5-1 plan
Richard D Francis
President and CEO · sold 23,393 at $32.46
759K
2.0% of stake
Mar 410b5-1 plan
Richard Daniell
EVP, Europe Commercial · sold 91,345 at avg $32.66
$2.98M
52% of stake
Mar 410b5-1 plan
Eric A Hughes
"See ""Remarks""" · sold 11,277 at $32.46
366K
10% of stake
Mar 410b5-1 plan
Christine Fox
EVP, U.S. Commercial · sold 9,098 at $32.46
295K
11% of stake
Mar 4No plan
Brian Savage
Interim Chief Legal Officer · sold 2,675 at avg $32.46
87K
24% of stake
Mar 310b5-1 plan
Richard Daniell
EVP, Europe Commercial · sold 128,985 at avg $32.36
$4.17M
51% of stake
Mar 3No plan
Brian Savage
Interim Chief Legal Officer · sold 1,274 at $32.36
41K
30% of stake
Mar 310b5-1 plan
Richard D Francis
President and CEO · sold 442,935 at avg $32.36
$14.3M
28% of stake
Mar 310b5-1 plan
Eric A Hughes
"See ""Remarks""" · sold 80,762 at avg $32.36
$2.61M
49% of stake
Feb 2610b5-1 plan
Eliyahu Sharon Kalif
EVP, Chief Financial Officer · sold 345,810 at $33.64
$11.6M
86% of stake
Feb 1510b5-1 plan
Richard D Francis
President and CEO · sold 447,778 at avg $34.22
$15.3M
43% of stake
Dec 16, 2025No plan
Amir Weiss
Chief Accounting Officer · sold 12,300 at $30.20
371K
69% of stake
Dec 16, 2025No plan
Roberto Mignone
Director · sold 77,400 at $30.24
$2.34M
14% of stake
Dec 9, 2025No plan
Richard Daniell
Exec. VP, European Commercial · sold 115,468 at $28.68
$3.31M
70% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TEVA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with TEVA

CompareIntrinsic value

UPCUniverse Pharmaceuticals Inc.

$1.47-1.34%39

REGNRegeneron Pharmaceuticals, Inc.

$930.67-4.39%54

VTRSViatris Inc.

$19.22+1.59%24

VRTXVertex Pharmaceuticals Incorporated

$549.04+3.44%47

BHCBausch Health Companies Inc.

$8.34+2.46%56

ZTSZoetis Inc.

$89.21+7.49%79

ONCBeOne Medicines Ltd.

$377.78+6.42%65

OGNOrganon & Co.

$13.83-0.14%28

Held by ETFs

TEVA is in 108 US ETFs. The largest of them, with TEVA's weight in each:

Spot a number that looks wrong? Check it in TEVA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing TEVA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.